FRESENIUS SE+CO.KGAA O.N. | 24.570 / -0.49% |
News
- UPDATE -- Humacyte Expands Strategic Global Partnership with Fresenius Medical Care
06/11/2021 / 21:03 - GlobeNewswire - Humacyte Expands Strategic Global Partnership with Fresenius Medical Care
06/11/2021 / 13:30 - GlobeNewswire - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS
11/11/2019 / 23:35 - GlobeNewswire - eGenesis Announces $100 Million Series B Financing
11/07/2019 / 12:00 - GlobeNewswire - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS
11/04/2019 / 23:27 - GlobeNewswire - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS
10/29/2019 / 18:45 - GlobeNewswire - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS
10/23/2019 / 18:05 - GlobeNewswire - Fresenius Medical buys NxStage for $2 billion
08/07/2017 / 07:39 - TeleTrader - Akorn Shareholders Vote to Approve Merger Agreement with Fresenius Kabi
07/19/2017 / 22:30 - GlobeNewswire - KISSEI TO MARKET AVACOPAN IN JAPAN FOR VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA
06/09/2017 / 06:58 - GlobeNewswire - Akorn Confirms Discussions with Fresenius Kabi
04/07/2017 / 23:59 - GlobeNewswire - Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab®
01/27/2011 / 08:31 - GlobeNewswire